Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03840525 · ClinicalTrials.gov registry record · Early Phase 1
A Mind Body Intervention to Reduce Symptoms Among People Aging With HIV
A Early Phase 1 study, sponsored by Florida International University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 48
- Enrollment target
NCT03840525: Completed Early Phase 1 study, sponsored by Florida International University.
NCT03840525 is a Early Phase 1 study that has completed, run by Florida International University. The registered enrollment target is 48 participants, roughly in line with the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03840525, a Early Phase 1 study, has completed, sponsored by Florida International University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
This study will develop and pilot test a qigong intervention with older people (50 and over) living with HIV. Participants (n=48) will be randomly assigned to one of 3 conditions: the qigong intervention, a sham qigong intervention, and a usual standard of care group. The study will determine the acceptability and feasibility of the study. If found effective, the qigong intervention will also improve the psychological and physical symptoms of older people living with HIV.
Primary Outcome
Satisfaction were measured by asking the following questions after each session: "I really enjoyed today's class"; "Today's class met my expectations"; "The instructor was engaged in today's class". Responses are on a 5 point Likert scale (1=strongly disagree to 5=strongly agree) with lower scores meaning less satisfaction. Both the qigong intervention and the sham qigong control group will be asked these satisfaction items. Acceptability was defined as responding either agree (4) or strongly ag
Interventions
- BEHAVIORAL The Qigong Intervention
- BEHAVIORAL Sham Qigong
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2022-09-30 |
| Phase | Early Phase 1 |
What the finished NCT03840525 record still lists
NCT03840525 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, roughly in line with the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which The Qigong Intervention is the first listed.
NCT03840525 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03840525 about?
NCT03840525 is a clinical study titled "A Mind Body Intervention to Reduce Symptoms Among People Aging With HIV". This study will develop and pilot test a qigong intervention with older people (50 and over) living with HIV. Participants (n=48) will be randomly assigned to one of 3 conditions: the qigong intervention, a sham qigong intervention, and a usual standard of care group. The study will determine the ac...
What is the current status of trial NCT03840525?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 48 participants. The study started on 2020-01-06. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT03840525?
The interventions under investigation include: The Qigong Intervention (BEHAVIORAL), Sham Qigong (BEHAVIORAL).
Who is sponsoring clinical trial NCT03840525?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03840525's enrollment target sits among peer trials
48 541st of 2000 higher than 1,439 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI